![Kunihiko Soneoka](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Kunihiko Soneoka has been the President, CEO & Representative Director of Sucampo Pharma LLC since 2006.
Kunihiko Soneoka active positions
Companies | Position | Start |
---|---|---|
Sucampo Pharma LLC
![]() Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan. | Chief Executive Officer | 01/11/2006 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Sucampo Pharma LLC
![]() Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan. | Commercial Services |
- Stock Market
- Insiders
- Kunihiko Soneoka